Inovio Pharmaceuticals Inc banner

Inovio Pharmaceuticals Inc
F:GBM

Watchlist Manager
Inovio Pharmaceuticals Inc Logo
Inovio Pharmaceuticals Inc
F:GBM
Watchlist
Price: 0.9285 EUR -0.16% Market Closed
Market Cap: €63.8m

Wall St Price Targets

GBM Price Targets Summary
Inovio Pharmaceuticals Inc

Wall Street analysts forecast GBM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GBM is 3.5085 EUR with a low forecast of 1.5346 EUR and a high forecast of 5.3178 EUR.

Lowest Forecast
Price Target
1.5346 EUR
65% Upside
Average Forecast
Price Target
3.5085 EUR
278% Upside
Highest Forecast
Price Target
5.3178 EUR
473% Upside
Inovio Pharmaceuticals Inc Competitors:
Price Targets
NSIT
Insight Enterprises Inc
-5% Downside
NCSM
NCS Multistage Holdings Inc
30% Upside
TTD
Trade Desk Inc
45% Upside
1981
Cathay Media and Education Group Inc
60% Upside
AYTU
Aytu Biopharma Inc
335% Upside
MEDP
Medpace Holdings Inc
-6% Downside
CFFN
Capitol Federal Financial Inc
3% Upside

Revenue
Forecast

-30% / Year
Past Growth
182% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-30% / Year
Past Growth
182% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been -30%. The projected CAGR for the next 8 years is 182%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Inovio Pharmaceuticals Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Inovio Pharmaceuticals Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GBM's stock price target?
Price Target
3.5085 EUR

According to Wall Street analysts, the average 1-year price target for GBM is 3.5085 EUR with a low forecast of 1.5346 EUR and a high forecast of 5.3178 EUR.

What is the Revenue forecast for Inovio Pharmaceuticals Inc?
Projected CAGR
182%

Over the last 14 years, the compound annual growth rate for Revenue has been -30%. The projected CAGR for the next 8 years is 182%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett